High expression of cereblon (CRBN) is associated with improved clinical response in patients with multiple myeloma treated with lenalidomide and dexamethasone

Autor:	Heintel, D, Rocci, A, Ludwig, H, Bolomsky, A, Caltagirone, S, Schreder, M, Pfeifer, S, Gisslinger, H, Zojer, N, Jäger, U, Palumbo, Antonio
Jazyk:	angličtina
Rok vydání:	2013
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=od_______970::82cb5f18ab1bacce11081a6d5b2cd2b5 http://hdl.handle.net/2318/145258 Zobrazit plný text záznamu